Bacillus clausii tablets（Qipian®）
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Overview
Bacillus clausii tablets（Qipian®） is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Bacillus clausii tablets（Qipian®） clinical trials
Explore related
Medical disclaimer. This page summarizes research about Bacillus clausii tablets（Qipian®） for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.